{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:40:07Z","timestamp":1756312807725,"version":"3.44.0"},"reference-count":29,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,5,26]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Mortality remains high in septic shock with few new treatment options. Angiotensin II has been recently approved for use in septic shock due to promising results in the ATHOS-3 trial. However, patients with neutropenia were excluded in the trial. This patient population is becoming increasingly common in the intensive care unit as there is an increase in novel biologic therapies and stem cell transplantations for haematological and solid organ malignancies. We present a case of a patient with T-cell acute lymphoblastic leukaemia who received chemotherapy, resulting in neutropenia and septic shock. There was persistent hypotension despite initiating multiple conventional vasopressors. Angiotensin II was attempted with immediate improvement in the blood pressure which resulted in weaning of other vasopressors. This positive haemodynamic response suggests that angiotensin II can successfully be used in neutropenic patients without increasing the overall catecholamine burden of septic shock.<\/jats:p>","DOI":"10.1136\/bcr-2019-233432","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T02:25:25Z","timestamp":1593397525000},"page":"e233432","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia"],"prefix":"10.1136","volume":"13","author":[{"given":"Albert D","family":"Bui","sequence":"first","affiliation":[{"name":"Critical Care, Mayo Clinic Florida, Jacksonville, Florida, USA"},{"name":"Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A","family":"Helgeson","sequence":"additional","affiliation":[{"name":"Critical Care, Mayo Clinic Florida, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K","family":"Guru","sequence":"additional","affiliation":[{"name":"Critical Care, Mayo Clinic Florida, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devang K","family":"Sanghavi","sequence":"additional","affiliation":[{"name":"Critical Care, Mayo Clinic Florida, Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,6,28]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.1","DOI":"10.1016\/S0140-6736(18)30696-2"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.2","DOI":"10.1001\/jama.2016.0289"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.3","DOI":"10.1001\/jama.2016.0287"},{"key":"2025082709050237000_13.6.e233432.4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/bja\/aex234","article-title":"Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database","volume":"119","author":"Shankar-Hari","year":"2017","journal-title":"Br J Anaesth"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.5","DOI":"10.1056\/NEJMoa1704154"},{"key":"2025082709050237000_13.6.e233432.6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.7","DOI":"10.1097\/CCM.0000000000000397"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.8","DOI":"10.1186\/cc2902"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.9","DOI":"10.1186\/cc8887"},{"key":"2025082709050237000_13.6.e233432.10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin II in septic shock","volume":"19","author":"Corr\u00eaa","year":"2015","journal-title":"Crit Care"},{"key":"2025082709050237000_13.6.e233432.11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ajem.2019.03.026","article-title":"Angiotensin II in septic shock","volume":"37","author":"Jadhav","year":"2019","journal-title":"Am J Emerg Med"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.12","DOI":"10.1517\/14728220903460332"},{"key":"2025082709050237000_13.6.e233432.13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jss.2013.08.004","article-title":"(Pro)renin receptor blocker improves survival of rats with sepsis","volume":"186","author":"Hirano","year":"2014","journal-title":"J Surg Res"},{"key":"2025082709050237000_13.6.e233432.14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CRD.0000000000000247","article-title":"Angiotensin II (Giapreza): a distinct mechanism for the treatment of vasodilatory shock","volume":"27","author":"Khalique","year":"2019","journal-title":"Cardiol Rev"},{"key":"2025082709050237000_13.6.e233432.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2017.08.433","article-title":"Comparison of Vasopressin and Epinephrine as the Second Vasopressor in the Treatment of Septic Shock","volume":"152","author":"Kim","year":"2017","journal-title":"Chest"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.16","DOI":"10.1056\/NEJMoa071366"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.17","DOI":"10.1007\/s00134-017-4683-6"},{"key":"2025082709050237000_13.6.e233432.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2025082709050237000_13.6.e233432.19","article-title":"Angiotensin II use in refractory multisystem shock: a case report","volume":"10","author":"Ahmed","year":"2018","journal-title":"Cureus"},{"key":"2025082709050237000_13.6.e233432.20","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for Postcardiopulmonary bypass Vasoplegic shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025082709050237000_13.6.e233432.21","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.athoracsur.2018.11.047","article-title":"Use of angiotensin II for post cardiopulmonary bypass Vasoplegic syndrome","volume":"108","author":"Evans","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2025082709050237000_13.6.e233432.22","article-title":"Unexpected bp sensitivity to angiotensin II in a patient with coronavirus disease 2019, ARDS, and septic shock","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"2025082709050237000_13.6.e233432.23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1213\/XAA.0000000000000775","article-title":"When all else fails: novel use of angiotensin II for vasodilatory shock: a case report","volume":"11","author":"Chow","year":"2018","journal-title":"A A Pract"},{"key":"2025082709050237000_13.6.e233432.24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/DCC.0000000000000414","article-title":"A patient with tricyclic antidepressant overdose with Catecholamine-Resistant hypotension rescued with angiotensin II: a case report","volume":"39","author":"Ferdowsali","year":"2020","journal-title":"Dimens Crit Care Nurs"},{"key":"2025082709050237000_13.6.e233432.25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccc.2018.11.003","article-title":"Angiotensin II in vasodilatory shock","volume":"35","author":"Wakefield","year":"2019","journal-title":"Crit Care Clin"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.26","DOI":"10.1016\/j.blre.2017.08.006"},{"key":"2025082709050237000_13.6.e233432.27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025082709050237000_13.6.e233432.28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bcp.2018.03.008","article-title":"The role of angiotensin II in cancer metastasis: potential of renin-angiotensin system blockade as a treatment for cancer metastasis","volume":"151","author":"Ishikane","year":"2018","journal-title":"Biochem Pharmacol"},{"doi-asserted-by":"publisher","key":"2025082709050237000_13.6.e233432.29","DOI":"10.1186\/s40425-018-0401-3"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:05:09Z","timestamp":1756310709000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,28]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bcr-2019-233432"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233432","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}